NewcelX Ltd. (NCEL) stock
NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)
Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –
NewcelX EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for NewcelX
NewcelX has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?